Skip to main content
World Journal of Gastroenterology logoLink to World Journal of Gastroenterology
. 2003 Sep 15;9(9):2117–2120. doi: 10.3748/wjg.v9.i9.2117

Inhibitory effect of all-trans retinoic acid on human hepatocellular carcinoma cell proliferation

Yun-Feng Piao 1, Yang Shi 1, Pu-Jun Gao 1
PMCID: PMC4656687  PMID: 12970919

Abstract

AIM: To study the inhibitory effect of all-trans retinoic acid on human hepatocellular carcinoma cell line SMMC-7721 and to explore the mechanism of its effect.

METHODS: SMMC-7721 cells were divided into two groups, one treated with all-trans retinoic acid (ATRA) for 5 days and the other as a control group. Light microscope and electron microscope were used to observe the morphological changes. Telomerase activity was analyzed with silver-stained telomere repeated assay protocal (TRAP). Expression of Caspase-3 was demonstrated with western blot.

RESULTS: ATRA-treated cells showed differentiation features including small and pyknotic nuclei, densely stained chromatin and fewer microvilli. Besides, ATRA could inhibit the activity of telomerase, promote the expression of Caspase-3 and its activation.

CONCLUSION: Telomerase activity and Caspase-3 expression are changed in human hepatocellular carcinoma cell line SMMC-7721 treated with all-trans retinioc acid. The inhibition of telomerase activity and the activation of Caspase-3 may be the key steps through which ATRA inhibits the proliferation of SMMC-7721 cell line.

INTRODUCTION

Several isomers have been found for retinoic acid (RA), an oxidative product of vitamin A, including all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9C-RA). ATRA has been used successfully in treatment of acute promyelocytic leukemia and other hematologic diseases[1-3]. It can induce cellular differentiation of many malignant tumors and inhibit their growth[4-11]. Morphological and biological changes were also observed in the human hepatocellular carcinoma (HCC) cell line SMMC-7721, treated with ATRA[12,13], but the mechanism remains obscure. For this reason, the changes in telomerase activity and Caspase-3 expression induced by ATRA were analyzed in SMMC-7721 in this study.

MATERIALS AND METHODS

Cell culture

The hepatocellular carcinoma cell line SMMC-7721, was kindly provided by the Hematology Institute of the First Hospital of Norman Bethune University of Medical Sciences, and cultivated in Iscove’s modified Dulbecco’s medium (IMDM, Gibco) containing 10% fetal bovine serum at 37 °C in an incubator with 5% CO2. During the exponential stage, ATRA was added to the medium (10-5 mmol/L). Cells growing in the ATRA-free medium were used as the control group.

Morphological observation

The ATRA-treated cells and the control cells were observed everyday. After 5 days, the cells were collected, stained and observed under the light microscope. About 107 cells were collected, washed with cold saline, and fixed with 4% glutaral and 1% osmium acid. After dehydration, embedding, sectioning and staining, the cells were observed under transmission electron microscope.

Activity of telomerase assayed by TRAP silver staining

About 2.5 × 105 cells were collected, washed and homogenized. The telomerase activity was detected using a TRAP kit following instructions of manufacturer (Beijing Tiangekangning biotech institute). The reaction system, containing 25 μL TRAP agent, 0.2 μL Taq enzyme and 1 μL cell extract, was incubated for 30 min at 25 °C. Then 0.5 μL of primer was added and PCR was conducted for 30 cycles with denaturing at 94 °C for 30 s, annealing at 60 °C for 30 s, extending at 72 °C for 30 s. 15 μL PCR products was loaded onto a 9% non-degenerative SDS gel, resolved through the SDS-PAGE, demonstrated by a reaction in 0.2% silver nitrate for 15 min, and visualized by incubation in 30 g/L anhydrous sodium carbonate containing formaldehyde (1 mL/L). The activity of telomerase was indicated by the presence of a 6 bp-DNA ladder. The cell extracts inactivated by incubation at 75 °C for 10 min were used as the negative control.

Expression of Caspase-3 assayed by western blot

About 106 SMMC-7721 cells were harvested, washed, and lyzed in the 5 volumes extract buffer (5 mM Tris-Cl (pH8.0), 150 mM NaCl, 5 mM EDTA, 1 mM DTT, 100 μg/mL PMSF, 2 μg/mL aprotinin, 1% NP-40) in the iced bath for 20 min. The supernatant was stored at -70 °C. After protein quantification, 80 μg of the extraction was subjected to SDS-PAGE. Proteins resolved on the gel were transferred to a nitrocellulose filter (Amersham) in the buffer containing 48 mmol/L Tris, 39 mmol/L glycocol, 0.037% SDS and 20% methanol. After being blocked in phosphate buffer saline containing 5% defatted milk, the blots were incubated with goat antibody against Caspase-3 (Santa Cruz). After being washed three times, the filter was incubated with HRP-labeled rabbit anti-goat immunoglobulin, and the reaction was visualized by incubation with a buffer containing DAB and H2O2.

RESULTS

Morphological changes

ATRA-treated cells appeared spindle-shaped, rather than polygon-shaped as under normal conditions. Their nuclei became smaller and pyknotic. The cytoplasma was also stained densely. Cell shrinkage, loss of microvilli, chromatin clumps and reduction of the nuclear/cytoplasmic ratio were noted under the electron microscope. The mitochondria proliferation, enlargement of Golgi complex, cytoplasmic vacuolation and glycogen accumulation, as well as lipofuscin and tonofilaments were also observed (Figure 1).

Figure 1.

Figure 1

Morphology of SMMC-7721 observed under trans-mission electron microscope. Untreated-cells have many microvilli, and their nuclei have a great of incisure (A). ATRA-treated cells have smaller volume, fewer microvilli on the surface, densed chromatin and increased heterochromatin. With the plasma increased, the nuclear/cytoplasmic ratio decreased. The mitochondria also increased. The Golgi com-plex became bigger. More vacuole and glycogen were seen. There were also many lipofuscin and tonofilaments (B).

Activity of telomerase

The untreated cells showed a 6 bp ladder pattern, suggesting the active telomerase, so it served as the positive control. The negative control did not show the pattern, the samples were inactivated at 75 °C. Similarly the ATRA-treated cells did not show the DNA ladder. We considered that ATRA could inhibit the telomerase activity (Figure 2).

Figure 2.

Figure 2

Telomerase activity of SMMC-7721. The untreated cells showed 6 bp ladder pattern, suggesting the active telomerase. So it served as the positive control (Lane 2). The negative control did not show the DNA ladder because the sample was inactivated at 75 °C (Lane 3). The ATRA-treated cells showed no ladder as the negative control (Lane 1).

Expression of Caspase-3

All the control groups showed a weak signal at the position of 32 kD, suggesting the presence of Caspase-3 expression at a low level. For the ATRA-treated cells, the 32 kD signal was shown to be strong. In addition, another signal at the position of 20 kD was detected. The latter represented the p20 subunit of Caspase-3, an active form of the molecule (Figure 3).

Figure 3.

Figure 3

The expression of Caspase-3. All the control groups showed weak signals at the position of 32kD, suggesting the presence of Caspase-3 (Lane 2). For the ATRA-treated cells, the 32kD signal was shown to be stronger. In addition, an-other signal at the position of 20kD was detected. The latter represented the p20 subunit of Caspase-3, an active form of the molecule (Lane 1).

DISCUSSION

It is estimated that about 437000 people die of HCC every year worldwide, and that their 5-year survival rate is below 3%. It is believed that development of HCC is associated with many factors[14-18]. Several gene mutations have been proven to play some roles during this process[19]. Eukaryotic chromosomes are capped with repetitive telomere sequences that appear important for maintaining chromosomal integrity. In all normal somatic cells, each cycle of cell division and DNA replication results in the loss of 50-200 terminal nucleotides from each chromosome. This gradually results in instability of the chromosomes and cell death[20,21]. Telomerase is a type of reverse transcriptase being essential in many cases for telomere stability and cell proliferation, immortalization and transformation[22-35].

Recently, more than ten types of proteases with homology to ICE/CED-3 that is specific to aspartic acid have been found. The Caspase family plays key biological roles in inflammatory responses and in regulation of apoptosis of mammalian cells. Among them, Caspase-3 is known as a key protease whose activation can induce apoptosis of mammalian cells[36-42]. It lies in the upper stream of a series of cascade reactions. Therefore, it may be of some help to delineate Caspase-3 expression during the ATRA-associated cell differentiation and death for further understanding of its mechanism.

In the present study, a reduction of telomerase activity, upregulation of Caspase-3 expression and the activation of this molecule were linked to the ATRA-induced differentiation of SMMC-7721 cells. A few mechanisms have been proposed for the growth inhibition of HCC cells by ATRA. For example, ATRA can inhibit telomerase activity and shorten telomere length of cancer cells and disrupt the stability of the chromosomes. Alternatively, Caspase may also be involved in this process. ATRA activates Caspase-3, stimulating a series of apoptotic signals and resulting in cell death. It is presumed that ATRA may directly or indirectly affect the function of Caspase-3 at the following three levels: 1) up-regulating the expression of Caspase-3; 2) indirectly acting on the upper stream regulator of Caspase-3; and 3) directly acting on Caspase-3 itself and promoting its activity. In conclusion, inactivation of telomerase and activation of Caspase-3 may be important pathways for the inhibition of HCC cell proliferation by ATRA.

Footnotes

Edited by Su Q

References

  • 1.Mologni L, Marchesi E, Nielsen PE, Gambacorti-Passerini C. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid. Cancer Res. 2001;61:5468–5473. [PubMed] [Google Scholar]
  • 2.Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res. 2001;61:2–7. [PubMed] [Google Scholar]
  • 3.Manfredini R, Trevisan F, Grande A, Tagliafico E, Montanari M, Lemoli R, Visani G, Tura S, Ferrari S, Ferrari S. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. Cancer Res. 1999;59:3803–3811. [PubMed] [Google Scholar]
  • 4.Chung J, Liu C, Smith DE, Seitz HK, Russell RM, Wang XD. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis. 2001;22:1213–1219. doi: 10.1093/carcin/22.8.1213. [DOI] [PubMed] [Google Scholar]
  • 5.Rexer BN, Zheng WL, Ong DE. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res. 2001;61:7065–7070. [PubMed] [Google Scholar]
  • 6.Sapi E, Flick MB, Tartaro K, Kim S, Rakhlin Y, Rodov S, Kacinski BM. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells. Cancer Res. 1999;59:5578–5585. [PubMed] [Google Scholar]
  • 7.Zhu WY, Jones CS, Amin S, Matsukuma K, Haque M, Vuligonda V, Chandraratna RA, De Luca LM. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Cancer Res. 1999;59:85–90. [PubMed] [Google Scholar]
  • 8.Miller WH. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer. 1998;83:1471–1482. doi: 10.1002/(sici)1097-0142(19981015)83:8<1471::aid-cncr1>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  • 9.Kalemkerian GP, Jiroutek M, Ettinger DS, Dorighi JA, Johnson DH, Mabry M. A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study. Cancer. 1998;83:1102–1108. doi: 10.1002/(sici)1097-0142(19980915)83:6<1102::aid-cncr8>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 10.Hatoum A, El-Sabban ME, Khoury J, Yuspa SH, Darwiche N. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis. 2001;22:1955–1963. doi: 10.1093/carcin/22.12.1955. [DOI] [PubMed] [Google Scholar]
  • 11.Schneider SM, Offterdinger M, Huber H, Grunt TW. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res. 2000;60:5479–5487. [PubMed] [Google Scholar]
  • 12.Ai ZW, Cha XL, Ye JN, Chen HL. Reverse effect of retinoic acid on some cell membrane phenotype of human hepatocellular carcinoma cells. Shengwu Huaxue yu Shengwu Wuli Xuebao. 1990;22:147–150. [Google Scholar]
  • 13.Ai ZW, Cha XL, Liu Y, Chen HL. Reverse effect of retinoic acid on some cell plasma phenotype of human hepatocellular carcinoma cells. Shengwu Huaxue yu Shengwu Wuli Xuebao. 1990;22:135–139. [Google Scholar]
  • 14.Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol. 2002;8:203–207. doi: 10.3748/wjg.v8.i2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ogami M, Ikura Y, Nishiguchi S, Kuroki T, Ueda M, Sakurai M. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab Invest. 1999;79:15–26. [PubMed] [Google Scholar]
  • 16.Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology. 1997;112:493–500. doi: 10.1053/gast.1997.v112.pm9024303. [DOI] [PubMed] [Google Scholar]
  • 17.Zhang G, Long M, Wu ZZ, Yu WQ. Mechanical properties of hepatocellular carcinoma cells. World J Gastroenterol. 2002;8:243–246. doi: 10.3748/wjg.v8.i2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wang X, Liu FK, Li X, Li JS, Xu GX. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro. World J Gastroenterol. 2002;8:253–257. doi: 10.3748/wjg.v8.i2.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ohno J, Horio Y, Sekido Y, Hasegawa Y, Takahashi M, Nishizawa J, Saito H, Ishikawa F, Shimokata K. Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development. Carcinogenesis. 2001;22:751–756. doi: 10.1093/carcin/22.5.751. [DOI] [PubMed] [Google Scholar]
  • 20.Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569–573. doi: 10.1038/350569a0. [DOI] [PubMed] [Google Scholar]
  • 21.Figueroa R, Lindenmaier H, Hergenhahn M, Nielsen KV, Boukamp P. Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors. Cancer Res. 2000;60:2770–2774. [PubMed] [Google Scholar]
  • 22.Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529. doi: 10.1016/0092-8674(89)90035-4. [DOI] [PubMed] [Google Scholar]
  • 23.Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: biological and clinical importance. Clin Chem. 1997;43:708–714. [PubMed] [Google Scholar]
  • 24.Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J. The RNA component of human telomerase. Science. 1995;269:1236–1241. doi: 10.1126/science.7544491. [DOI] [PubMed] [Google Scholar]
  • 25.Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015. doi: 10.1126/science.7605428. [DOI] [PubMed] [Google Scholar]
  • 26.Toomey D, Smyth G, Condron C, Kay E, Conroy R, Foley D, Hong C, Hogan B, Toner S, McCormick P, et al. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features. Cancer. 2001;92:2648–2657. doi: 10.1002/1097-0142(20011115)92:10<2648::aid-cncr1618>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  • 27.Hytiroglou P, Kotoula V, Thung SN, Tsokos M, Fiel MI, Papadimitriou CS. Telomerase activity in precancerous hepatic nodules. Cancer. 1998;82:1831–1838. [PubMed] [Google Scholar]
  • 28.Kitamoto M, Ide T. Telomerase activity in precancerous hepatic nodules. Cancer. 1999;85:245–248. doi: 10.1002/(sici)1097-0142(19990101)85:1<245::aid-cncr37>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 29.Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer. 1997;74:141–147. doi: 10.1002/(sici)1097-0215(19970422)74:2<141::aid-ijc1>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  • 30.Yan P, Coindre JM, Benhattar J, Bosman FT, Guillou L. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res. 1999;59:3166–3170. [PubMed] [Google Scholar]
  • 31.Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res. 2000;60:610–617. [PubMed] [Google Scholar]
  • 32.Yan P, Saraga EP, Bouzourene H, Bosman FT, Benhattar J. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. J Pathol. 2001;193:21–26. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH728>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  • 33.Youssef N, Paradis V, Ferlicot S, Bedossa P. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J Pathol. 2001;194:459–465. doi: 10.1002/path.901. [DOI] [PubMed] [Google Scholar]
  • 34.Sato N, Maehara N, Mizumoto K, Nagai E, Yasoshima T, Hirata K, Tanaka M. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer. 2001;91:496–504. doi: 10.1002/1097-0142(20010201)91:3<496::aid-cncr1028>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  • 35.Matthews P, Jones CJ, Skinner J, Haughton M, de Micco C, Wynford-Thomas D. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications. J Pathol. 2001;194:183–193. doi: 10.1002/path.848. [DOI] [PubMed] [Google Scholar]
  • 36.Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43. doi: 10.1038/376037a0. [DOI] [PubMed] [Google Scholar]
  • 37.Wolf BB, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem. 1999;274:20049–20052. doi: 10.1074/jbc.274.29.20049. [DOI] [PubMed] [Google Scholar]
  • 38.Marshman E, Ottewell PD, Potten CS, Watson AJ. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol. 2001;195:285–292. doi: 10.1002/path.967. [DOI] [PubMed] [Google Scholar]
  • 39.Sané AT, Bertrand R. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Cancer Res. 1999;59:3565–3569. [PubMed] [Google Scholar]
  • 40.Mori M, Terui Y, Tanaka M, Tomizuka H, Mishima Y, Ikeda M, Kasahara T, Uwai M, Ueda M, Inoue R, et al. Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity: activation of caspase-3 and nuclear factor-kappaB. Cancer Res. 2001;61:4414–4417. [PubMed] [Google Scholar]
  • 41.Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res. 2001;61:3062–3070. [PubMed] [Google Scholar]
  • 42.Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C, Foster BA, Greenberg N, Spencer DM, Slawin KM. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Cancer Res. 2001;61:2562–2571. [PubMed] [Google Scholar]

Articles from World Journal of Gastroenterology are provided here courtesy of Baishideng Publishing Group Inc

RESOURCES